Astigmatism Correction Carl Zeiss Case Studies Empowering Providers with the Multimodal Maestro2 Extending dosing of anti-VEGF High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

Astigmatism Correction Carl Zeiss Case Studies Empowering Providers with the Multimodal Maestro2 Extending dosing of anti-VEGF High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

View More Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Medical World News

Eyeviews Medical World News Podcasts Rapid Readouts Viewpoints

Digital Edition

Supplements And Featured Publications

Digital Edition Supplements And Featured Publications

Conference Coverage

Conference Listing

Sponsored Resources

Zeiss Case Studies

Sponsored Resources Zeiss Case Studies

Print Subscription

eNewsletter Print Subscription

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Astigmatism Correction
Carl Zeiss Case Studies
Empowering Providers with the Multimodal Maestro2
Extending dosing of anti-VEGF
High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma
iCare COMPASS Automated Perimeter
Optimizing clinical care and practice efficiency with multimodal Triton™ imaging

ClinicalSee All >

Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences^™ and Opthalmology Times Europe. All rights reserved.

Ranibizumab leading the anti-VEGF evolution

February 7, 2014

Considerations and new perspectives in anti-VEGF therapy.

Related Content:

Sponsored Resources

Efficacy and safety of intravitreal aflibercept (Eylea®) therapy using a proactive treat-and-extend regimen in neovascular AMD

Keeping a step ahead of the disease: proactive treatment for nAMD

CenterVue EIDON FA: the FIRST Fully Automated Fluorescein Angiography system